C2R-63032-72186
5 vaccinations
22 coded responses
39 check-ins
21 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 922 / CA
- Registered
- 2021-08-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-24
Dose 1 — Pfizer-BioNTech
-
2021-08-25
Registered in v-safe
-
2021-08-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-08-26
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Armpit swollen lymph nodesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-28
Survey response — days 1–6 daily, dose 1MedDRA: Sleep disorder — Feeling: Poor · Site: Itching · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Disrupted sleepMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-29
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Itching around bodyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Persistent itchingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-31
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swollen lymph in armpitsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-07
Survey response — day 14, dose 1MedDRA: Decreased appetite, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea and loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Dose 2 — Pfizer-BioNTech
-
2021-09-14
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Slight dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Difficulty sleepingMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Nasal congestion — Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Nasal stuffiness and coughMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Nasal stuffinessMedDRA releases: 2024-11 · check-in free text available
-
2021-09-18
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Redness, Itching · Muscle or body aches, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Absolutely no appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-19
Survey response — days 1–6 daily, dose 2MedDRA: Skin exfoliation — Feeling: Poor · Site: Redness · Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Some skin peelingMedDRA releases: 2024-11 · check-in free text available
-
2021-09-20
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Still no appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Survey response — day 7, dose 2MedDRA: Decreased appetite — Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Still no appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Survey response — day 14, dose 2MedDRA: Nausea, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Arm pain and nauseaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — day 21, dose 2MedDRA: Fatigue, Nausea, Parosmia, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Very nauseated. Sensitivity to smells. Extreme fatigue. · Healthcare visit (other): LabworkMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-12
-
2021-10-19
Survey response — day 35, dose 2MedDRA: Ageusia, Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shortness of breath, loss of tasteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-26
- 2021-12-01
- 2021-12-06
- 2021-12-14
-
2022-02-15
Dose 3 — Pfizer-BioNTech
-
2022-03-15
Survey response — 6 months, dose 2MedDRA: Cough — Feeling: Fair · Be unable to work or attend schoolFree text: Worsening coughMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Dose 4 — Pfizer-BioNTech
- 2022-09-16
-
2022-10-14
Dose 5 — Pfizer-BioNTech
-
2022-10-14
Health check-in — day 0, dose 5Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-15
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-16
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-17
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-18
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Swelling, Itching · Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-19
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-20
Health check-in — days 1–6 daily, dose 5Feeling: Good · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-21
Health check-in — day 7, dose 5Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 28, dose 5MedDRA: Asthenia, Back pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: My lower back has become very painful and weakMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — day 35, dose 5MedDRA: Arthralgia, Back pain, Dysstasia, Mobility decreased — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Low back and hip pain on one side; difficulty standing and bendingMedDRA releases: 2024-11 · check-in free text available
-
2022-11-25
Survey response — day 42, dose 5MedDRA: Dysstasia, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme fatigue. Unable to stand up to for more than a few minutes.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-13
-
2023-04-14
Survey response — 6 months, dose 5MedDRA: Herpes zoster — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-24 | Pfizer-BioNTech | No |
| 2 | 2021-09-14 | Pfizer-BioNTech | No |
| 3 | 2022-02-15 | Pfizer-BioNTech | No |
| 4 | 2022-06-15 | Pfizer-BioNTech | No |
| 5 | 2022-10-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Armpit swollen lymph nodes
Systemic reaction (other): Disrupted sleep
Systemic reaction (other): Itching around body
Systemic reaction (other): Persistent itching
Release 9 — day 7, dose 1
Systemic reaction (other): Swollen lymph in armpits
Release 9 — day 14, dose 1
Symptoms: Nausea and loss of appetite
Release 9 — day 0, dose 2
Systemic reaction (other): Slight dizziness
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Difficulty sleeping
Systemic reaction (other): Nasal stuffiness and cough
Systemic reaction (other): Nasal stuffiness
Systemic reaction (other): Absolutely no appetite
Systemic reaction (other): Some skin peeling
Systemic reaction (other): Still no appetite
Release 9 — day 7, dose 2
Systemic reaction (other): Still no appetite
Release 9 — day 14, dose 2
Symptoms: Arm pain and nausea
Release 10 — day 21, dose 2
Symptoms: Very nauseated. Sensitivity to smells. Extreme fatigue.
Healthcare visit (other): Labwork
Release 10 — day 35, dose 2
Symptoms: Shortness of breath, loss of taste
Release 11 — 6 months, dose 2
Symptoms: Worsening cough
Release 12 — day 28, dose 5
Symptoms: My lower back has become very painful and weak
Release 12 — day 35, dose 5
Symptoms: Low back and hip pain on one side; difficulty standing and bending
Release 12 — day 42, dose 5
Symptoms: Extreme fatigue. Unable to stand up to for more than a few minutes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Dysstasia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Pruritus | ✓ | · | ✓ |
| SRO | Skin exfoliation | · | · | ✓ |
| SRO | Sleep disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release